Zurich Cantonal Bank’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$1.17M Buy
24,129
+1,036
+4% +$50.4K ﹤0.01% 1145
2025
Q1
$786K Buy
23,093
+876
+4% +$29.8K ﹤0.01% 1312
2024
Q4
$874K Buy
22,217
+645
+3% +$25.4K ﹤0.01% 1264
2024
Q3
$1.01M Buy
21,572
+98
+0.5% +$4.6K ﹤0.01% 1119
2024
Q2
$1.16M Buy
21,474
+1,884
+10% +$102K ﹤0.01% 997
2024
Q1
$1.34M Sell
19,590
-969
-5% -$66K ﹤0.01% 920
2023
Q4
$1.29M Buy
20,559
+2,032
+11% +$127K ﹤0.01% 927
2023
Q3
$841K Buy
18,527
+1,879
+11% +$85.3K ﹤0.01% 1066
2023
Q2
$935K Buy
16,648
+842
+5% +$47.3K ﹤0.01% 969
2023
Q1
$715K Buy
15,806
+931
+6% +$42.1K ﹤0.01% 1081
2022
Q4
$605K Buy
14,875
+1,097
+8% +$44.6K ﹤0.01% 1140
2022
Q3
$900K Sell
13,778
-34,427
-71% -$2.25M 0.01% 879
2022
Q2
$2.93M Sell
48,205
-3,612
-7% -$219K 0.02% 589
2022
Q1
$3.25M Sell
51,817
-2,074
-4% -$130K 0.02% 616
2021
Q4
$4.08M Buy
53,891
+7,627
+16% +$578K 0.02% 586
2021
Q3
$5.18M Buy
46,264
+831
+2% +$93K 0.03% 503
2021
Q2
$7.36M Buy
45,433
+6,066
+15% +$982K 0.04% 392
2021
Q1
$4.8M Buy
39,367
+3,907
+11% +$476K 0.03% 493
2020
Q4
$5.43M Buy
35,460
+10,941
+45% +$1.68M 0.03% 463
2020
Q3
$2.05M Buy
24,519
+1,074
+5% +$89.8K 0.01% 686
2020
Q2
$1.72M Buy
23,445
+4,406
+23% +$324K 0.01% 674
2020
Q1
$807K Sell
19,039
-360
-2% -$15.3K 0.01% 781
2019
Q4
$1.18M Buy
19,399
+16,529
+576% +$1.01M 0.01% 787
2019
Q3
$118K Buy
2,870
+343
+14% +$14.1K ﹤0.01% 1524
2019
Q2
$119K Hold
2,527
﹤0.01% 1513
2019
Q1
$90K Hold
2,527
﹤0.01% 1640
2018
Q4
$72K Sell
2,527
-300
-11% -$8.55K ﹤0.01% 1800
2018
Q3
$125K Hold
2,827
﹤0.01% 1586
2018
Q2
$166K Buy
2,827
+1,127
+66% +$66.2K ﹤0.01% 1355
2018
Q1
$78K Sell
1,700
-3,600
-68% -$165K ﹤0.01% 1755
2017
Q4
$124K Hold
5,300
﹤0.01% 1459
2017
Q3
$95K Buy
+5,300
New +$95K ﹤0.01% 1436